# Melatonin Associated to Acid Inhibition for Chemoprevention in Barret Esophagus: a Pilot Study

> **NCT01566474** · PHASE3 · COMPLETED · sponsor: **Aragon Institute of Health Sciences** · enrollment: 80 (actual)

## Conditions studied

- Barrett's Esophagus

## Interventions

- **DRUG:** Omeprazole
- **DRUG:** Melatonin

## Key facts

- **NCT ID:** NCT01566474
- **Lead sponsor:** Aragon Institute of Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2019-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01566474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01566474, "Melatonin Associated to Acid Inhibition for Chemoprevention in Barret Esophagus: a Pilot Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01566474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*